UnknownNCT00836524

Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zealand University Hospital
Principal Investigator
Estrid Høgdall, PhD leader
Dept of Pathology Herlev Hospital, Denmark
Intervention
ultrasound(procedure)
Enrollment
2000 target
Eligibility
18-50 years · FEMALE
Timeline
20092012

Study locations (1)

Collaborators

Region Zealand · University of Copenhagen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00836524 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials